Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind
extension study for patients who participated in study NK-104-305.